# Risk-Adapted Omission of Level Va Irradiation in Nasopharyngeal Carcinoma

> **NCT07268690** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Fujian Cancer Hospital** · enrollment: 474 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma by AJCC V9 Stage

## Interventions

- **RADIATION:** Omission of Level Va Irradiation in Nasopharyngeal Carcinoma

## Key facts

- **NCT ID:** NCT07268690
- **Lead sponsor:** Fujian Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 474 (ESTIMATED)
- **Last updated:** 2025-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07268690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07268690, "Risk-Adapted Omission of Level Va Irradiation in Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07268690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*